Impact of CSF Storage Volume on the Analysis of Alzheimer's Disease Biomarkers on an Automated Platform

Overview

Journal Clin Chim Acta

Specialty Biochemistry

Date 2018 Dec 24

PMID 30579960

Citations 10

Authors

Constance Delaby

Laia Munoz

Soraya Torres

Alicia Nadal

Nathalie Le Bastard

Sylvain Lehmann

Alberto Lleo

Daniel Alcolea

Affiliations

Soon will be listed here.

Abstract

Objectives: To assess the potential influence of the ratio between the storage tube surface area and the volume of cerebrospinal fluid (CSF) (surface/volume) on the quantifications of four Alzheimer's disease (AD) biomarkers on the Lumipulse G600II automated platform.

Methods: CSF samples of 10 consecutive patients were stored in 2 ml polypropylene tubes containing four different CSF volumes: 1.5 ml, 1 ml, 0.5 ml and 0.25 ml. Concentration of CSF Aβ1-42, Aβ1-40, t-Tau and p-Tau were measured in all aliquots using the LUMIPULSE G600II automated platform from Fujirebio.

Results: Levels of CSF Aβ1-42 and Aβ1-40 were lower in samples stored with lower volumes (higher surface/volume ratios). This decrease was partly compensated by using the ratio Aβ1-42/Aβ1-40. Quantification of t-Tau and p-Tau were not influenced by this pre-analytical condition.

Conclusion: The surface/volume ratio can potentially influence the results of amyloid AD biomarkers. It appears essential to take into account the surface/volume ratio of the storage tubes when quantifying CSF biomarkers in clinical routine.

Citing Articles

PSEN2 Mutations May Mimic Frontotemporal Dementia: Two New Case Reports and a Review.

Minguillon Pereiro A, Quintans Castro B, Ouro Villasante A, Aldrey Vazquez J, Cortes Hernandez J, Aramburu-Nunez M Biomedicines. 2024; 12(8).

PMID: 39200345 PMC: 11351743. DOI: 10.3390/biomedicines12081881.

A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer's Disease.

Arcaro M, Fenoglio C, Serpente M, Arighi A, Fumagalli G, Sacchi L Biomedicines. 2022; 10(10).

PMID: 36289929 PMC: 9599653. DOI: 10.3390/biomedicines10102667.

The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone.

Delaby C, Estelles T, Zhu N, Arranz J, Barroeta I, Carmona-Iragui M Alzheimers Res Ther. 2022; 14(1):20.

PMID: 35105351 PMC: 8809019. DOI: 10.1186/s13195-022-00967-z.

An Improved Deep Residual Network Prediction Model for the Early Diagnosis of Alzheimer's Disease.

Sun H, Wang A, Wang W, Liu C Sensors (Basel). 2021; 21(12).

PMID: 34207145 PMC: 8235495. DOI: 10.3390/s21124182.

P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status.

Campbell M, Ashrafzadeh-Kian S, Petersen R, Mielke M, Syrjanen J, Van Harten A Alzheimers Dement (Amst). 2021; 13(1):e12190.

PMID: 34027020 PMC: 8129859. DOI: 10.1002/dad2.12190.